Cormorant Asset Management

Cormorant Asset Management as of June 30, 2017

Portfolio Holdings for Cormorant Asset Management

Cormorant Asset Management holds 71 positions in its portfolio as reported in the June 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Portola Pharmaceuticals 8.4 $51M 900k 56.17
Theravance Biopharma (TBPH) 6.3 $38M 950k 39.84
Bluebird Bio (BLUE) 4.8 $29M 275k 105.05
Quotient 4.3 $26M 3.5M 7.36
Omeros Corporation (OMER) 4.3 $26M 1.3M 19.91
Galapagos Nv- (GLPG) 3.8 $23M 300k 76.39
Juno Therapeutics 3.7 $22M 750k 29.89
Nevro (NVRO) 3.3 $20M 270k 74.43
Aclaris Therapeutics (ACRS) 3.2 $20M 720k 27.12
Anaptysbio Inc Common (ANAB) 3.2 $19M 800k 23.93
Blueprint Medicines (BPMC) 3.1 $19M 368k 50.67
Proteostasis Therapeutics In 3.0 $18M 3.8M 4.68
Minerva Neurosciences 2.9 $18M 2.0M 8.85
Clearside Biomedical (CLSD) 2.9 $18M 1.9M 9.11
Eagle Pharmaceuticals (EGRX) 2.6 $16M 200k 78.89
Ignyta 2.6 $16M 1.5M 10.35
Myokardia 2.2 $13M 1.0M 13.10
Gemphire Therapeutics 2.0 $12M 953k 12.89
Neurocrine Biosciences (NBIX) 1.9 $12M 250k 46.00
Alder Biopharmaceuticals 1.7 $10M 900k 11.45
Alnylam Pharmaceuticals (ALNY) 1.6 $10M 125k 79.76
Coherus Biosciences (CHRS) 1.5 $8.9M 620k 14.35
G1 Therapeutics 1.4 $8.4M 480k 17.44
Heron Therapeutics (HRTX) 1.3 $7.9M 570k 13.85
Array BioPharma 1.2 $7.5M 900k 8.37
Ardelyx (ARDX) 1.2 $7.3M 1.4M 5.10
Audentes Therapeutics 1.0 $6.2M 324k 19.13
Protagonist Therapeutics (PTGX) 0.9 $5.7M 500k 11.31
Synergy Pharmaceuticals 0.9 $5.3M 1.2M 4.45
Dex (DXCM) 0.8 $5.1M 70k 73.16
Contrafect 0.8 $5.1M 3.6M 1.45
Invuity 0.8 $5.1M 700k 7.25
Jounce Therapeutics 0.8 $5.0M 360k 14.03
Dermira 0.8 $5.0M 170k 29.14
Syros Pharmaceuticals 0.8 $4.8M 296k 16.09
Fulgent Genetics (FLGT) 0.8 $4.8M 750k 6.39
Agenus 0.8 $4.7M 1.2M 3.91
Agile Therapeutics 0.8 $4.7M 1.3M 3.75
Intec Pharma 0.8 $4.6M 810k 5.70
Rigel Pharmaceuticals 0.7 $4.2M 1.5M 2.73
Curis 0.6 $3.8M 2.0M 1.89
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 0.6 $3.8M 300k 12.51
Wave Life Sciences (WVE) 0.6 $3.8M 202k 18.60
Cytomx Therapeutics (CTMX) 0.6 $3.6M 230k 15.50
Sangamo Biosciences (SGMO) 0.6 $3.5M 400k 8.80
Sorrento Therapeutics (SRNE) 0.6 $3.4M 1.7M 2.00
Immune Design 0.5 $3.3M 337k 9.75
Lipocine 0.5 $3.0M 742k 4.02
Advanced Accelerat spon ads each rep 2 ord 0.5 $2.9M 75k 39.04
Trillium Therapeutics, Inc. Cmn 0.4 $2.6M 600k 4.40
Abeona Therapeutics 0.4 $2.6M 400k 6.40
Recro Pharma 0.4 $2.3M 333k 7.03
Regenxbio Inc equity us cm (RGNX) 0.4 $2.4M 120k 19.75
Ovid Therapeutics (OVID) 0.4 $2.3M 224k 10.49
Acceleron Pharma 0.4 $2.3M 75k 30.39
Pfenex 0.4 $2.3M 575k 4.01
Zymeworks 0.3 $1.9M 232k 8.35
Xencor (XNCR) 0.3 $1.6M 75k 21.11
Aptose Biosciences 0.2 $1.2M 991k 1.23
Portola Pharmaceuticals 0.2 $1.2M 1.0k 1160.00
Myovant Sciences 0.2 $1.2M 100k 11.70
Mersana Therapeutics (MRSN) 0.2 $1.1M 80k 13.97
Oncobiologics 0.2 $1.0M 1.0M 1.01
Abbvie 0.2 $939k 6.1k 153.93
Htg Molecular Diagnostics 0.1 $541k 204k 2.66
Threshold Pharmaceuticals 0.1 $351k 900k 0.39
Neos Therapeutics 0.1 $369k 51k 7.29
Cellectar Biosciences 0.0 $87k 54k 1.62
Oncobiologics Inc *w exp 02/18/201 0.0 $71k 417k 0.17
Oncobiologics Inc *w exp 05/18/201 0.0 $38k 417k 0.09
Cellectar Biosciences Equity Warrants *w 0.0 $12k 53k 0.23